November 01, 2025
The osteoarthritis therapeutics market size is expected to see growth from USD 11.92 billion in 2026 to USD 24...
Read MoreJanuary 21, 2026
The medical device CMO and CDMO market is expected to see growth from USD 52.57 billion in 2026 to USD 110.82 ...
Read MoreNovember 13, 2025
The hospital services market is predicted to grow from USD 13.19 trillion in 2026 to USD 28.99 trillion by 203...
Read MoreMarch 04, 2026
The simulators market size is forecast to increase from USD 14.71 billion in 2026 to USD 27.59 billion by 2035...
Read MoreNovember 01, 2025
Market insights predict the global sports medicine industry will increase from USD 6.28 billion in 2024 to USD 11.90 billion by 2034, achieving a CAGR of 6.6%. In 2024, body reconstruction products dominated with a 41% market share. Knee injuries led demand, making up 32% of the market. North America remained the top region, commanding a 42% share....
November 01, 2025
Forecasts suggest that the mHealth market will expand from USD 69.24 billion in 2024 to USD 260.56 billion by 2034, with a CAGR of 14.17% during this period. Wearables are projected to grow at a 7.5% CAGR, while mHealth apps led with 72% market share in 2023. Remote patient monitoring dominated with 27% market share, and patients took the lead as k...
November 01, 2025
Based on market forecasts, the advanced drug delivery sector will expand from USD 245.64 billion in 2024 to USD 385.14 billion by 2034, experiencing a CAGR of 4.6%. In 2023, oral drug delivery led the market with a 48% share, while controlled release followed closely at 42%. North America held the largest share at 38%, but Asia Pacific is the one t...
November 01, 2025
According to market projections, the retinitis pigmentosa sector is expected to grow from USD 14.89 billion in 2024 to USD 27.17 billion by 2034, reflecting a CAGR of 6.2%. In 2023, Autosomal Recessive RP dominated with 65% market share, but gene therapy is gaining traction at 23%, bringing new hope. North America leads the market, yet Asia Pacific...
November 01, 2025
According to market projections, the ulcerative colitis treatment sector is expected to grow from USD 10.58 billion in 2024 to USD 15.81 billion by 2034, reflecting a CAGR of 4.1%. The battle against ulcerative colitis is heating up! Pancolitis, the most widespread form, accounted for 34% of cases in 2023. Anti-TNF biologics lead treatment options ...
November 01, 2025
According to market projections, the glutamine sector is expected to grow from USD 135.13 million in 2024 to USD 185.16 million by 2034, reflecting a CAGR of 3.2%.The glutamine market was dominated by L-glutamine, the biologically active form used for protein synthesis in 2023. The powder segment led due to its convenience and stability. Offline re...
November 01, 2025
Based on market forecasts, the atrial fibrillation treatment sector will expand from USD 24.26 billion in 2024 to USD 40.27 billion by 2034, experiencing a CAGR of 5.2%. Atrial fibrillation is a heart rhythm problem where the upper chambers quiver, raising the risk of blood clots. Causes include high blood pressure, heart disease, and sleep apnea. ...
November 01, 2025
Forecasts suggest that the synovial sarcoma treatment market will expand from USD 852.36 million in 2024 to USD 1214 million by 2034, with a CAGR of 3.6% during this period. In 2023, surgery remained the leading treatment, holding a dominant 56% market share. North America led the market, accounting for 41% of the total share....
November 01, 2025
According to market projections, the autoimmune hepatitis diagnosis and treatment sector is expected to grow from USD 14.49 billion in 2024 to USD 20.05 billion by 2034, reflecting a CAGR of 3.3%. The autoimmune hepatitis diagnosis and treatment market focuses on tests and therapies for managing autoimmune hepatitis, a condition where the immune sy...
November 01, 2025
According to market projections, the vein finder sector is expected to grow from USD 53.43 million in 2024 to USD 123.04 million by 2034, reflecting a CAGR of 8.7%. In 2023, near-infrared technology led the vein finder market with a 57% share, while tabletop models dominated at 55%. Hospitals and clinics were the top users, holding 62% of the marke...
+1 804 441 9344
+61 4859 81310 or +91 87933 22019
sales@towardshealthcare.com